|1.||Gorbachev, A G: 3 articles (11/2006 - 11/2003)|
|2.||Al'-Shukri, S Kh: 3 articles (11/2006 - 11/2003)|
|3.||Kuz'min, I V: 3 articles (11/2006 - 11/2003)|
|4.||Borovets, S Iu: 2 articles (11/2006 - 09/2005)|
|5.||Belousov, V Ia: 2 articles (11/2006 - 09/2005)|
|6.||Gomon, O N: 2 articles (07/2006 - 03/2005)|
|7.||Malinin, V V: 1 article (07/2012)|
|8.||Savateeva-Liubimova, T N: 1 article (07/2012)|
|9.||Sivak, K V: 1 article (07/2012)|
|10.||Chushkin, K A: 1 article (11/2006)|
05/01/1997 - "Normalization of hemostasis seems to be one of the factors of prostatilen therapeutic efficacy in chronic prostatitis. "
05/01/1997 - "[The effect of prostatilen on the hemostatic indices in chronic prostatitis (a clinical and experimental study)]."
07/01/2004 - "[Polypeptide prostatilen in the treatment of patients with complicated prostatitis]."
05/01/1997 - "As to patients with chronic prostatitis, there were also prostatilen-induced platelet-vascular hemostatic normalization and fibrinolysis activation. "
05/01/1997 - "Prostatilen effects on hemostasis were studied in 120 intact and 240 chronic prostatitis rats, 34 patients with chronic prostatitis. "
|2.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/01/2006 - "This suggests possibility of suppository prostatilen use not only as an alternative for expensive drugs but also in combination with them in treatment of initial prostatic adenoma."
11/01/2006 - "[Prostatilen treatment of prostatic adenoma]."
09/01/2005 - "The authors review the experience with prostatilen treatment gained in the urological clinic of the St-Petersburg State Medical University and analyze treatment outcomes for 96 patients with benign prostatic hyperplasia (BPH) aged from 51 to 89 years. "
09/01/2005 - "[Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia]."
03/01/2005 - "Prooxidant-antioxidant balance in the prostate and blood of rats with sulpyride[corrected]-induced prostatic hyperplasia corrected with prostatilen."
11/01/2003 - "It is shown that prostatilen has a corrective effect on hemocoagulation and immunity disorders, restores microcirculation, suppresses inflammation in the kidney and prostate. "
11/01/2003 - "Thus, prostatilen is a pathogenetically sound drug for treatment in urogenital inflammation while in chronic prostatitis it can be used as a basic therapy."
|1.||Suppositories (Vaginal Suppositories)
|4.||Dimethyl Sulfoxide (DMSO)
|6.||Immunologic Factors (Immunomodulators)
|9.||Ascorbic Acid (Vitamin C)